Skip to content
10-Q

Quarterly Report

NEXUS BIOPHARMA INC

0001213900-16-017692

← back to feed
Filed
Oct 24, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Oct 24, 2016 64.3M sh
Cash And Equivalents Q2 2017 · Aug 31, 2016 $62.44K
Cash And Equivalents Q2 2017 · Feb 29, 2016 $9.93K
Cash And Equivalents Q2 2017 · Feb 28, 2015 $22.05K
Current Liabilities Q2 2017 · Aug 31, 2016 $1.23M
Current Liabilities Q2 2017 · Feb 29, 2016 $735.61K
Total Liabilities Q2 2017 · Aug 31, 2016 $1.28M
Total Liabilities Q2 2017 · Feb 29, 2016 $776.72K
Current Assets Q2 2017 · Aug 31, 2016 $62.44K
Current Assets Q2 2017 · Feb 29, 2016 $9.93K
Total Assets Q2 2017 · Aug 31, 2016 $70.21K
Total Assets Q2 2017 · Feb 29, 2016 $9.93K
Sga Expense Q2 2017 · Aug 31, 2016 $161.4K
Sga Expense Q2 2017 · Aug 31, 2016 $409.42K
Sga Expense Q2 2017 · Aug 31, 2015 $761.22K
Sga Expense Q2 2017 · Aug 31, 2015 $803.27K
Rd Expense Q2 2017 · Aug 31, 2016 $8.9K
Rd Expense Q2 2017 · Aug 31, 2016 $16.4K
Rd Expense Q2 2017 · Aug 31, 2015 $7.5K
Rd Expense Q2 2017 · Aug 31, 2015 $110.9K
Net Income Q2 2017 · Aug 31, 2016 −$179.34K
Net Income Q2 2017 · Aug 31, 2016 −$439K
Net Income Q2 2017 · Aug 31, 2015 −$768.72K
Net Income Q2 2017 · Aug 31, 2015 −$914.17K